No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the country Sara BravacciniMassimiliano MazzaRoberta Maltoni Editorial 13 June 2023 Pages: 1 - 3
Identifying miRNA biomarkers for breast cancer and ovarian cancer: a text mining perspective Xin LiAndrea DaiJie Wang Review 17 June 2023 Pages: 5 - 14
Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer Senbang YaoQianqian ZhangHuaidong Cheng Review 17 June 2023 Pages: 15 - 26
Heterogeneous circulating tumor cells correlate with responses to neoadjuvant chemotherapy and prognosis in patients with locally advanced breast cancer Ge MaJingyi WangShui Wang Preclinical study 13 June 2023 Pages: 27 - 41
Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells Taronish D. DubashAditya BardiaShyamala Maheswaran Preclinical study Open access 15 June 2023 Pages: 43 - 56
Conventional specimen radiography in breast-conserving therapy: a useful tool for intraoperative margin assessment after neoadjuvant therapy? Benedikt SchäfgenAnnabelle HallerMichael Golatta Clinical trial Open access 11 June 2023 Pages: 57 - 66
Radiofrequency localization of nonpalpable breast cancer in a multicentre prospective cohort study: feasibility, clinical acceptability, and safety Anke ChristenhuszBianca M. den DekkerAnneriet E. Dassen Clinical trial Open access 15 June 2023 Pages: 67 - 75
Impact of non-adherence to endocrine therapy on recurrence risk in older women with stage I breast cancer after breast-conserving surgery Danielle RodinRinku SutradharEileen Rakovitch Epidemiology 16 June 2023 Pages: 77 - 87
Survival benefits associated with being adherent and having longer persistence to adjuvant hormone therapy across up to five years among U.S. Medicare population with breast cancer Dandan ZhengJoseph Thomas III Epidemiology 16 June 2023 Pages: 89 - 104
Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2− MBC in the real world Megan KruseEmily Nash SmythKevin Kalinsky Epidemiology 13 June 2023 Pages: 105 - 115
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer Eileen Rillamas-SunMarilyn L. KwanHeather Greenlee Epidemiology 16 June 2023 Pages: 117 - 126
Surviving the COVID-19 pandemic: navigating the recovery of breast imaging services in a safety-net hospital Jessica H. PorembkaStephen J. SeilerBasak E. Dogan Epidemiology 18 June 2023 Pages: 127 - 138
Validating the PROMIS cognitive function short form in cancer survivors Ashley M. HenneghanKathleen Van DykPatricia A. Ganz Original Laboratory Investigation 17 June 2023 Pages: 139 - 145
Is there any association between declined creatinine clearence and higher endoxifen levels in older patients with non-metastatic breast cancer? Kadri Altundag Letter to the Editor 17 June 2023 Pages: 147 - 147
It is the impact of racism, not race, that causes breast cancer inequities Francois G. RollinShub S. AgrawalMackenzie L. W. Garcia Letter to the Editor 19 June 2023 Pages: 149 - 150